PCR-based identification of eight lactobacillus species and 18 hr-HPV genotypes in fixed cervical samples of south african women at risk of HIV and BV

Diagnostic Cytopathology

Volumn 40, Issue 6, 2012, Pages 472-477

  Dols, Joke A M ^a,b,c   Reid, Gregor ^c   Kort, Remco ^d   Schuren, Frank H J ^d   Tempelman, Hugo ^e   Bontekoe, Tj Romke ^f   Korporaal, Hans ^b   Van Der Veer, E M ^b   Smit, Pieter W ^b   Boon, Mathilde E ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN CYTOLOGY AND PATHOLOGY LABORATORY   (Netherlands)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d TNO   (Netherlands)

^e NDLOVU CARE GROUP   (South Africa)

^f Bontekoe Research   (Netherlands)

Author keywords

BV; HIV; HPV; Lactobacillus species; microarray

Indexed keywords

BACTERIUM IDENTIFICATION; CONFERENCE PAPER; FEMALE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN TISSUE; LACTOBACILLUS; LACTOBACILLUS SALIVARIUS; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; NONHUMAN; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTH AFRICA; UTERINE CERVIX; WART VIRUS;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALPHAPAPILLOMAVIRUS; BIOFILMS; COINFECTION; FEMALE; FIXATIVES; GENOTYPE; GENOTYPING TECHNIQUES; HIV INFECTIONS; HUMANS; LACTOBACILLUS; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTORS; SOUTH AFRICA; TISSUE FIXATION; VAGINA; VAGINOSIS, BACTERIAL;

EID: 84861577350     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21786     Document Type: Conference Paper

References (19)

1. Klomp JM, Verbruggen BSM, Korporaal H, et al. Gardnerella vaginalis and Lactobacillus sp in liquid-based cervical samples in healthy and disturbed vaginal flora using cultivation-independent methods. Diagn Cytopathol 2008; 36: 277-284.
2. Watts DH, Fazarri M, Minkoff H, et al. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J Infect Dis 2005; 191: 1129-1139.
3. Muñoz N, Bosch FX, Castellsagué X, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004; 111: 278-285.
4. Boon ME, Kok LP,. Formalin cross-linking or optimized alcohol coagulation: That is the question. In:, Pandalai SG, editor. Recent research development in human pathology. Trivandrum, Kerala, India: Transworld Research Network; 2005. p 17-38.
5. Kleter B, van Doorn LJ, Schrauwen L, et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999; 37: 2508-2517.
6. Zaura E, Keijser BJ, Huse SM, Crielaard W,. Defining the healthy "core microbiome" of oral microbial communities. BMC Microbiol 2009; 15: 259.
7. Nocker A, Richter T, Montijn R, Schuren F, Kort R,. Live/dead discrimination in 454 pyrosequencing based bacterial community analysis of environmental water samples. Int Microbiol 2010; 13: 59-65.
8. Dols JAM, Smit PW, Kort R, et al. Microarray-based identification of clinically relevant vaginal bacteria in relation to bacterial vaginosis. Am J Obstet Gynecol 2011; 204: 305.e1-e7.
9. Vlaminckx BJ, Schuren FH, Montijn RC, et al. Determination of the relationship between group A streptococcal genome content. M type, and toxic shock syndrome by a mixed genome microarray. Infect Immun 2007; 75: 2603-2611.
10. Cole JR, Wang Q, Cardenas E, et al. The ribosomal database project: Improved alignments and new tools for rRNA analysis. Nucleic Acids Res 2009; 37: D141-D145.
11. Coelho Lima BM, Golub JE, Tonani Mattos A, Freitas LB, Cruz Spano L, Espinosa Miranda A,. Human papillomavirus in women with and without HIV-1 infection attending an STI clinic in Vitoria. Brazil J Int Assoc Physicians AIDS Care (Chic III) 2009; 8: 286-290.
12. Van Hamont D, van Ham MAPC, Bakkers JMJE, Massuger LFAG, Melchers WJG,. Evaluation of the SPF-10 INNO LiPA human papillomavirus (HPV) genotyping test and the Roche Linear Array HPV genotyping test. J Clin Microbiol 2006; 44: 3122-3129.
13. Choi HS, Kim KM, Kim CH, Kim SM, Seok J,. Hyrogen peroxide producing lactobacilli in women with cervical neoplasia. Cancer Res Treat 2006; 38: 108-111.
14. Kim TK, Thomas SM, Ho M, et al. Heterogeneity of vaginal microbial communities within individuals. J Clin Microbiol 2009; 47: 1181-1189.
15. Ravel J, Gajer P, Abdo Z, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci USA 2010; 108 (Suppl 1): 4680-4687.
16. Conti C, Malacrino C, Mastromarino P,. Inhibition of herpes simplex virus type 2 by vaginal lactobacilli. J Physiol Pharmacol 2009; 60: 19-26.
17. Hummelen R, Fernandes AD, Macklaim JM, et al. Deep sequencing of the vaginal microbiota of women with HIV. PLoS One 2010; 5: e12078.
18. Verstraelen H, Verhelst R, Claeys G, De Backer E, Temmerman M, Vaneechoutte M,. Longitudinal analysis of the vaginal microflora in pregnancy suggests that L. crispatus promotes the stability of the normal vaginal microflora and that L. gasseri and/or L. iners are more conducive to the occurrence of abnormal vaginal microflora. BMC Microbiol 2009; 9: 116.
19. Macklaim JM, Gloor GB, Anukam KC, Cribby S, Reid G,. At the crossroads of vaginal health and disease, the genome sequence of Lactobacillus iners AB-1. Proc Natl Acad Sci USA 2011; 108 (Suppl 1): 4688-4695.